News | May 15, 2007

Monebo Remote, Wireless ECG Monitoring Belt Cleared in U.S.

May 16, 2007 — Monebo Technologies Inc. has announced that the CardioBelt Electrode System is now available, following clearance by the FDA.

The CardioBelt is an ECG acquisition device used for remote patient monitoring, including the assessment of heart arrhythmias. It will be integrated into the platform technologies of home heath care and telemedicine equipment providers, in devices ranging from computers to cell phones, and will work in concert with other devices that monitor blood pressure, weight, glucose level, and oxygen saturation, to provide physicians a more complete assessment of their patients health while the patient stays in the comfort of their own home.

The CardioBelt is designed for patient ease of use, and to allow healthcare professionals to quickly obtain accurate information on their patient's ECG. It is worn across the chest, with no patient preparation, sticky electrodes or cables, eliminating the need for a trained health professional to be physically present. The patient puts the belt on, pushes one button, and the CardioBelt connects wirelessly to a communication device, leaving the patient with total mobility.

CardioBelt works with Monebo's ECGAnalyzer software, designed for the healthcare professional and used to interpret the ECG signal once it is received at the central location. It provides easy to use, yet powerful ECG monitoring tools, and helps with the efficiency of handling multiple patients. Together, the system provides a cost effective and patient liberating solution to cardiac electrical monitoring, making it an excellent alternative for patients in a homecare or distance care setting.

For more information visit www.monebo.com

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
AUM Cardiovascular Receives FDA Approval for CADence ECG Device
Technology | ECG| August 08, 2017
AUM Cardiovascular announced it has received clearance from the U.S. Food and Drug Administration (FDA) for CADence, a...
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
More Than 20 Percent of Low-Risk Patients Receive Annual ECG
News | ECG| July 20, 2017
July 20, 2017 — More than one in five Ontario patients receive an ...
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Overlay Init